Body CompositionNCT07282080
Discover Better Body Composition With Green Light!
A study testing EmeraldLED in people with Body Composition, run by Efforia, Inc at 1 site in United States.
Trial summary
Investigation into Green Light Therapy study using EmeraldLED for 15-minute sessions, twice a week, to support positive changes in body composition. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Body Composition
- What is being tested?
- EmeraldLED
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Aug 2025to 15 Aug 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Who cannot join
- -individuals with eye conditions
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Efforia
New York, New York, 10003
Matthew Amsden, (646) 679-2479, help@efforia.com
About this study
Investigation into Green Light Therapy study using EmeraldLED for 15-minute sessions, twice a week, to support positive changes in body composition.
Read the detailed description
This remotely administered decentralized trial is designed to rigorously explore the efficacy of green light therapy in influencing body composition and overall well-being. Under the leadership of Ryan, CEO of beem® Light Sauna, this study leverages the expansive network of over 50 wellness franchise locations across the United States, along with 30 years of fitness and wellness industry experience, to investigate the science-backed potential of green light therapy. Amidst the widespread speculation and anecdotal evidence circulating on social media, investigators seek to provide concrete, personalized data to participants, thereby empowering them with the knowledge to make informed decisions about their health and wellness strategies.
The core objective of this online study is to empower participants by providing a detailed analysis of how exposure to green light impacts their weight management journey and overall sense of well-being. By participating in this study, individuals will receive tailored feedback on their body composition changes and psychological well-being, offering a unique opportunity to understand the potential benefits of green light therapy on a personal level.
Participants in this remotely conducted trial will engage with state-of-the-art green light therapy sessions from the comfort of their chosen environment, ensuring a broad and inclusive participant base without geographic limitations. This approach not only facilitates a more diverse data set but also aligns with our commitment to making health innovations accessible to a wider audience.
The significance of this study cannot be overstated, as it aims to demystify the claims surrounding green light therapy and its effects on weight management and mental health. By contributing to this pioneering research, participants will be at the forefront of a potential paradigm shift in the approach to wellness and body composition optimization. While acknowledging the limitations of this study and the need for further extensive trials, the insights gained here will be invaluable in guiding future health innovations and strategies, marking a significant step towards a healthier, more informed society.
- Conditions
- Body Composition
- Being tested
- EmeraldLED
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EmeraldLEDDevice
This device is a customizable, multi-wavelength therapeutic system designed for individualized cosmetic treatments. It features an easy-to-use interface with preprogrammed treatment categories, a wide pulsing frequency range from 1 to 15,000 Hz, and independent wavelength control for precise protocol tailoring. The system delivers five wavelengths-450 nm, 525 nm, 650 nm, 810 nm, and 980 nm-with an output power of 3,325 W and irradiance up to 119 mW/cm².
The green light EmeraldLED therapy provided in this study is set at 525 nm.
| Study group | Role | What they receive |
|---|---|---|
| Single arm where participants act as their own control | Experimental | Single arm where participants act as their own control Receives: Device: EmeraldLED |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Image and Self-Perception Survey
This survey aims to understand an individual's perception of their body, attractiveness, and physical functionality. It contains multiple-choice questions with five options ranging from 'Strongly Disagree' to 'Strongly Agree'. The questions are divided into three categories: Body Satisfaction, Attractiveness Evaluation, and Physical Functionality Awareness.
Measured: Change from baseline (Day 1-3) in body image and self-perception at 4 weeks after the start of the intervention (Day 27-33)
Body Composition Measurement Form
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be recorded in centimeters to maintain uniformity and precision.
Measured: Change from baseline (Day 1-3) in body composition measurements at 4 weeks after the start of the intervention (Day 27-33)
Quality of Life and Health Survey
This survey asks about your feelings towards your quality of life, health, and various areas of your life. It covers your experiences and feelings in the past four weeks. Please choose the answer that appears most appropriate.
Measured: Change from baseline (Day 1-3) in quality of life and health perceptions at 4 weeks after the start of the intervention (Day 27-33)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Dec 2025
- Study start15 Aug 2025
- Primary completion15 Aug 2026 (estimated)
- Study completion15 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Body CompositionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Single Arm observational where participants act as their own control
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Efforia, Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07282080
- Sponsor's protocol ID
- 43172
- Status last verified
- Dec 2025
- First submitted
- 5 Dec 2025
- Last updated
- 23 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes